426844-77-1 Usage
General Description
(2S,4S)-4-Fluoropyrrolidine-2-carbonitrile Hydrochloride is a chemical compound with potential applications in the pharmaceutical industry. It is a derivative of pyrrolidine and contains a fluorine atom and a cyano group. (2S,4S)-4-Fluoropyrrolidine-2-carbonitrile Hydrochloride may have properties that make it suitable for use in the development of pharmaceutical drugs, as it can potentially interact with biological systems or be used as a starting material for the synthesis of other compounds. The hydrochloride salt form of this compound is likely to be more stable and easier to handle in a lab setting, making it more suitable for research and development purposes. Further research and testing are needed to fully understand the potential uses and properties of (2S,4S)-4-Fluoropyrrolidine-2-carbonitrile Hydrochloride.
Check Digit Verification of cas no
The CAS Registry Mumber 426844-77-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,6,8,4 and 4 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 426844-77:
(8*4)+(7*2)+(6*6)+(5*8)+(4*4)+(3*4)+(2*7)+(1*7)=171
171 % 10 = 1
So 426844-77-1 is a valid CAS Registry Number.
426844-77-1Relevant articles and documents
NOVEL 4-FLUOROPYRROLIDINE-2-CARBONYL FLUORIDE COMPOUNDS AND THEIR PREPARATIVE METHODS
-
Page/Page column 37, (2010/08/04)
Novel 4-fluoropyrrolidine-2-carbonyl fluoride compounds as useful fluorinated intermediates are disclosed. Their preparative methods are also disclosed. Useful applications of the 4-fluoropyrrolidine-2-carbonyl fluorides are shown.
Therapeutic compounds
-
Page/Page column 13, (2008/06/13)
The invention provides compounds of formula (I), prodrugs and stereoisomers thereof, and the pharmaceutically acceptable salts of the compounds, prodrugs, and stereoisomers, wherein R1, R2, R3, HET, n, Q, X, Y, and Z are as described herein; compositions thereof; and uses thereof in treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.
